CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
53.85
+0.33 (0.62%)
Aug 10, 2026, 12:31 PM EDT - Market open
CRISPR Therapeutics AG Market Cap
CRISPR Therapeutics AG has a market cap or net worth of $5.21 billion as of August 10, 2026. Its market cap has increased by 4.09% in one year.
Market Cap
5.21B
Enterprise Value
3.63B
1-Year Change
4.09%
Ranking
Category
Stock Price
$53.85
ChartMarket Cap Chart
Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from $560.10M to $5.21B, an increase of 829.64%. That is a compound annual growth rate of 25.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 5.21B | 4.19% |
| Dec 31, 2025 | 5.00B | 48.76% |
| Dec 31, 2024 | 3.36B | -32.44% |
| Dec 29, 2023 | 4.97B | 56.24% |
| Dec 30, 2022 | 3.18B | -45.12% |
| Dec 31, 2021 | 5.80B | -46.39% |
| Dec 31, 2020 | 10.82B | 221.74% |
| Dec 31, 2019 | 3.36B | 126.76% |
| Dec 31, 2018 | 1.48B | 53.95% |
| Dec 29, 2017 | 963.10M | 19.42% |
| Dec 30, 2016 | 806.50M | 43.99% |
| Oct 19, 2016 | 560.10M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xenon Pharmaceuticals | 6.09B |
| PTC Therapeutics | 6.03B |
| Dianthus Therapeutics | 6.02B |
| Definium Therapeutics | 6.01B |
| Oruka Therapeutics | 5.89B |
| Travere Therapeutics | 5.77B |
| Ligand Pharmaceuticals | 5.70B |
| ACADIA Pharmaceuticals | 5.00B |